PhD in Biology from Sorbonne University (2002), Stéphanie Kervestin began her research career at UMass Medical School before joining CNRS in 2006. She later held leadership roles in innovation and partnerships at CNRS and the French Ministry of Research. In 2022, she became General Delegate of Ariis and board member of the IA & Cancer Initiative.
Ariis is a public-private alliance fostering collaboration between healthcare industry players and academic research institutions, promoting innovation and accelerating partnerships in health and life sciences.
